• Advances in the Understanding of Etiology (I)
• 30 min
  1. Infection and autoimmunity: a two-way relationship

  • Dr. Ricard Cervera
• 35 min
  2. Autoimmunity and atherosclerosis

  • Prof. Johan Frostegard
• 47 min
  3. Endothelium and autoimmunity

  • Prof. Pier Luigi Meroni
• Advances in the Understanding of Etiology (II)
• 22 min
  4. Prolactin has a pathogenic role in systemic lupus erythematosus

  • Prof. Luis Jara-Quezada
• 44 min
  5. Sjögren's syndrome: current knowledge and future prospects

  • Prof. Athanasios G. Tzioufas
• 51 min
  6. Genetic and environmental triggers of autoimmune thyroid diseases

  • Prof. Yaron Tomer
• Advances in Pathogenesis and Clinical Manifestation
• 38 min
  7. The catastrophic antiphospholipid syndrome and the microangiopathic antiphospholipid syndrome

  • Prof. Ronald Asherson
• 20 min
  8. Pathogenic mechanisms of autoantibodies: circulating and local antibodies that form immune complexes

  • Dr. Luís Eduardo Coelho Andrade
• 34 min
  9. Pathogenic mechanisms of autoantibodies: antibodies to intracellular and membrane-bound antigens

  • Dr. Luís Eduardo Coelho Andrade
• 43 min
  10. What causes primary biliary cholangitis?

  • Dr. M. Eric Gershwin
• 30 min
  11. Capillaroscopy in autoimmune rheumatic diseases

  • Prof. Maurizio Cutolo
• Advances in Diagnostic Methodologies (I)
• 26 min
  12. The past, present & future of ANA testing: history and challenges of ANA

  • Prof. Marvin J. Fritzler
• 33 min
  13. The past, present & future of ANA testing: changing bandwidth and future of ANA

  • Prof. Marvin J. Fritzler
• 36 min
  14. Diagnostic methods in autoimmunity

  • Mr. Steven Binder
• 24 min
  15. Systemic lupus erythematosus: novel aspects of pathogenesis and treatment 1

  • Prof. Chaim Putterman
  • Dr. Noa Schwartz
• 28 min
  16. Systemic lupus erythematosus: novel aspects of pathogenesis and treatment 2

  • Prof. Chaim Putterman
  • Dr. Noa Schwartz
• 48 min
  17. Novel aspects of systemic sclerosis

  • Prof. Gabriele Valentini
• Advances in Diagnostic Methodologies (II)
• 46 min
  18. An update on the multiple faces of celiac disease

  • Prof. Aaron Lerner
• 23 min
  19. Protective autoantibodies

  • Prof. Elias Toubi
• 32 min
  20. CD44 genetic deletion enhances and CD44 antibody targeting attenuates autoimmune inflammation

  • Prof. David Naor
• 44 min
  21. Rheumatic fever: a model of a post-infectious autoimmune disease

  • Prof. Jorge Kalil
• Treatments of autoimmune diseases
• 38 min
  22. Intravenous immunoglobulins: clinical evidence

  • Prof. Shaye Kivity
• Latest Developments in the Field
• 26 min
  23. Adjuvants and autoimmunity

  • Dr. Eitan Israeli
• 46 min
  24. Antiphospholipid syndrome (APS): from pathogenesis to treatment

  • Prof. Roger Levy
• 24 min
  25. Vitamin D and autoimmunity

  • Dr. Shir Azrielant
• 28 min
  26. Pregnancy in rheumatic diseases

  • Prof. Pier Luigi Meroni
• Archived Lectures *These may not cover the latest advances in the field
• 47 min
  27. Pathogenic mechanisms of autoantibodies

  • Prof. Cees Kallenberg
• 41 min
  28. B lymphocytes on the frontline of autoimmunity

  • Prof. Pierre Youinou
• 42 min
  29. Apoptotic cell clearance deficiency

  • Prof. Martin Herrmann
• 34 min
  30. Auto-antibodies as predictors of autoimmune disease

  • Dr. Nicola Bizzaro
• 46 min
  31. Innate immunity and natural autoantibodies

  • Prof. Luc Mouthon
• 45 min
  32. Accelerated atherosclerosis in autoimmune rheumatic disease

  • Dr. Andrea Doria
• 47 min
  33. Pregnancy in autoimmune rheumatic diseases

  • Prof. Angela Tincani
• 42 min
  34. Pulmonary hypertension in the connective tissue disease pathogenesis, clinical features and therapeutic options in 2006

  • Prof. Ronald Asherson
• 39 min
  35. Use of algorithms for high quality diagnostics and handling of patients with autoimmune rheumatic diseases

  • Dr. Allan Wiik
• 24 min
  36. Immunologic mechanisms in systemic lupus erythematosus

  • Prof. Kok-Yong Fong
• 23 min
  37. Osteoimmunology

  • Prof. João Eurico Fonseca
  • Ms. Joana Caetano-Lopes
• 43 min
  38. ANCA-associated systemic vasculitides

  • Prof. Loic Guillevin
• 23 min
  39. The common origin for diverse autoimmune diseases

  • Prof. Juan-Manuel Anaya
• 76 min
  40. Anti-cytokine therapy in rheumatoid arthritis

  • Prof. Piercarlo Sarzi-Puttini
• 40 min
  41. Sjogren's syndrome: autoimmune epithelitis

  • Prof. Haralampos Moutsopoulos
• 31 min
  42. Vitamin D and autoimmunity

  • Dr. Howard Amital
• 25 min
  43. Intravenous immunoglobulins: myth and reality

  • Prof. Zera Tellier

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Pregnancy and the immune system
3. SLE and flares during pregnancy
4. Pregnancies and patients studied
5. Flare definition applied in pregnancy
6. Physician judgement and disease activity index
7. Flare definition
8. Timing of SLE flares in pregnancy
9. Flare frequency by timing of pregnancy
10. ECLAM score / estrogen levels during pregnancy
11. Can we know flare occurrences in advance ?
12. Significant predictors of flares
13. Pregnant women with SLE can have flares
14. Gestational outcome in SLE
15. Impact of lupus activity on obstetric outcome
16. Gestational outcome in SLE: example
17. Gestational outcome in renal SLE
18. Identifying patients with a high risk of baby loss
19. Predictors of adverse pregnancy outcome
20. Predictors of obstetrical /neonatal complications
21. Factors that predict prematurity and preeclampsia
22. Autoantibodies that affect pregnancy outcome
23. Antiphospholipid (APL) antibody definition
24. Antiphospholipid (APL) antibody associations
25. Beta-2 glycoprotein I (beta-2GPI)
26. Two-hit theory in APS
27. Placenta: the target of aPL
28. Beta-2GPI binds the trophoblast cell membranes
29. Revised classification for APS syndrome
30. Antiphospholipid antibodies and autoimmunity
31. APS is treatable cause of prgnancy loss
32. Obstetrical complications
33. Newborns from mothers with primary APS (1)
34. Newborns from mothers with primary APS (2)
35. Thrombosis in the offspring of APS patients
36. Transplacental passage of IgG aPL (1)
37. Transplacental passage of IgG aPL (2)
38. aPL in 12 month old babies
39. The influence on fetal development
40. Mental developement and maternal autoAbs (1)
41. Mental developement and maternal autoAbs (2)
42. Clinical success and open questions
43. Register of infants from mothers with APS
44. IgG isotope can influence pregnancy
45. Ro complex
46. Anti-Ro/anti-La and autoimmunity
47. Anti Ro/SS-A and gestational outcome
48. Neonatal lupus model
49. Anti Ro/SS-A and congenital heart block (CHB)
50. Proposed mechanism of cardiac damage
51. The diagnosis of CHB
52. In utero detection of first-degree heart block
53. Management of CHB
54. Antenatal and postnatal exposure to DEX
55. 11 CHB children with/without exposure to DEX
56. T-cell evaluation in eight DEX exposed children
57. Heteroduplex analysis on TCRBV chains
58. Oligoclonal expansions of TCR repertoire
59. Alessa - case study
60. Second pregnancy - case study
61. Acknowledgements and contacts

Topics Covered

• Pregnancy and the immune system
• SLE flares during pregnancy
• Gestational outcome in SLE
• Predictors of obstetrical and neonatal complications in SLE
• Autoantibodies that can affect pregnancy outcome: antiphospholipid antibodies
• Obstetrical complications and newborns outcome in antiphospholipid syndrome
• Autoantibodies that can affect pregnancy outcome: anti-Ro/SS-A antibodies
• Neonatal lupus
• Congenital heart block and in utero exposure to dexamethasone

Links

Series:

• Autoimmunity

Categories:

• Clinical Practice
• Immunology

Therapeutic Areas:

• Gynaecology & Obstetrics
• Immunology & Inflammation

Talk Citation

Publication History

• Published on October 1, 2007
• Archived on May 31, 2018

Financial Disclosures

• Prof. Angela Tincani has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.